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A differential diagnosis of a head and neck bony lesion:
Review of a case series with 18 patients with extraintestinal
features of familial adenomatous polyposis
1 | INTRODUCTION
We would like to draw to the attention of head and neck surgeons
the following disease that can present first to head and neck special-
ists with either a head and neck lump or following an incidental find-
ing on radiological imaging.
Familial adenomatous polyposis (FAP) is a hereditary disease
caused by a mutation in the APC gene on chromosome 5, which
is inherited in an autosomal dominant fashion with complete
penetrance but variable expression.1 However in approximately
25% of cases, it arises from a de novo mutation of the APC
gene.1 FAP affects between 1 in 13 000 and 18 000 live births
in the Northern European population2 and is characterised by
hundreds to thousands of colorectal polyps, which almost inevita-
bly lead to colorectal cancer (CRC) by the age of 35-40 years
without a prophylactic proctocolectomy.2,3 In the Swedish Famil-
ial Adenomatous Polyposis Registry, the median age of diagnosis
with CRC was 42 years, and the median age of diagnosis with-
out CRC was 34, with asymptomatic relatives diagnosed at a
median age of 22 years. The average age of progression to col-
orectal carcinoma is 35-40 years.2 As the disease is multisystem,
there are multiple extracolonic manifestations, affecting endo-
derm, ectoderm and mesoderm layers. Endodermal lesions include
intestinal polyps and various carcinomas including thyroid, pan-
creas, adrenals; ectodermal lesions include the epidermoid cyst,
CNS tumours, especially medulloblastomas, desmoid tumours,
lipomas and mesodermal lesions include osteomas and dental
abnormalities.2,4
Among these FAP patients, those with benign extracolonic fea-
tures such as osteomas, desmoid tumours, epidermoid cysts, or
skin fibromas have a subtype named Gardner syndrome,1,5,6 origi-
nally described by Gardner in 1953.7 Another subtype is called
Turcot syndrome, in which patients have FAP associated with
CNS tumours.2,4
FAP should be considered in the differential diagnosis for head
and neck lumps, as one of the common features of this disease is
osteomas, often multiple, along with soft tissue tumours, which can be
found in the head and neck region.2 The extraintestinal features of
FAP can present many years before the development of symptomatic
abdominal polyposis,5,8 which can present an excellent opportunity to
begin screening and management of the condition.
We present a series of 18 patients with FAP who were found to
have osteomas, a proportion of whom were first seen with osteomas
by an otolaryngologist—head and neck surgeon, maxillofacial sur-
geon or dentist. These can either be found incidentally on OPG and
referred on, or be referred by primary care as a hard lump in the
head and neck region.
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2 | METHODS
We used the Finnish research registry for FAP, which has recorded
all the Finnish cases of FAP, which covers patients and their families
since 1963-2017. Included in the registry are 419 patients from 179
families. The FAP patients were diagnosed by endoscopic screening
or, from the year 1996 onwards, by genetic testing in combination
with endoscopy. Retrospective review of the medical notes of these
419 patients identified the presence of osteomas and site if
recorded, date and method of diagnosis of FAP.
Ethics/Permissions: The FAP registry obtains a research permit from
the Finnish National Institute for Health and Welfare (Dnro. THL/1068/
5.05.00/2015) and an institutional Research Ethics Board Approval
(Dnro. 104/13/03/02/2015) at the Helsinki University Hospital.
3 | RESULTS
The FAP registry demographics were 222 (53%) female, 197 (47%)
male. Median age of diagnosis of FAP was 30 years, range 0-87,
interquartile (IQ) range 19-45. A total of 194 patients (46%) were
diagnosed based on symptoms, 142 (34%) were asymptomatic and
diagnosed with colonoscopy screening, and 83 (20%) were asymp-
tomatic, diagnosed with APC gene analysis.
Osteoma was found in 18 patients, which is 4.3% of patients in
the FAP registry. These patients are described in Table 1. In six
(33%) of these 18 patients, an osteoma was the first presentation of
the disease to a healthcare professional, and they were subsequently
diagnosed with FAP. Ten (55%) had multiple osteomas at presenta-
tion, and 8 (45%) had a solitary osteoma at presentation.
4 | DISCUSSION
This was a review of the registry based on the diagnoses available.
These FAP patients were not routinely screened radiologically for
osteomas; therefore, these findings and diagnoses have been inci-
dental. The patients who were found to have osteomas were of a
similar gender distribution to the general FAP population. Patients
who presented first with osteomas were diagnosed at a median age
of 20 years. Interestingly, there was no significant difference
between the ages at diagnosis in the patients who presented first
with the osteoma compared to the group with osteomas present.
Keypoints
• Familial adenomatous polyposis (FAP) is an autosomal
dominant cancer syndrome.
• FAP can affect most body systems, and patients can
develop osteomas and tumours of the skin, which can be
detected before the onset on cancer.
• We present 18 patients from a register of 419 patients
with FAP who reportedly had an osteoma. Two thirds
(94%) of these patients had osteomas in the mandible or
maxilla.
• One-third of the patients with osteomas presented first
with the osteomas and were subsequently diagnosed
with FAP.
• The presence of osteomas can predate the development
of symptoms in FAP by many years.
TABLE 1 Patient demographics and osteoma location
Osteomas present Osteoma diagnosed first
Osteomas found after
FAP diagnosis
n= 18 6 12
Sex Female 9 2 7
Male 9 4 5
Age at presentation when
diagnosed first
with osteoma
6, 14, 15, 15, 30, 38
Age at FAP diagnosis Range, average,
median
5-57, 26.4, 21.5 15-40, 23.3, 20
(ages corresponding with above
patients: 21, 19, 15, 15, 30, 40)
Osteoma site Maxilla 5
Mandible 12 (1 of these was later
re-diagnosed as an
osteoblastoma.)
Frontal bone 3
Skull 7
Elsewhere 2 (forearm, limb)
Number of
osteomas
Multiple 10
Solitary 8
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However, three of the six patients who first presented with osteo-
mas were still not diagnosed with FAP until 2, 5 and 15 years later.
In these cases, the diagnosis of FAP would have been possible much
earlier if the clinicians were aware of FAP syndrome; however due
to the limited sample size, it is difficult to infer whether this is repre-
sentative.
In our sample, the most common site of osteomas was in the
mandible, in keeping with the literature where the angle of the
mandible is the most common location.2,9 Interestingly, one diag-
nosed osteoma was later reclassified as an osteoblastoma.
Osteoblastoma in FAP has not previously been reported in the Eng-
lish literature.
Patients with osteomas, especially if multiple, or if associated
with other soft tissue tumours and/or dental abnormalities should be
investigated for FAP, given the severity of the condition and the
implications of delayed diagnosis for development of colorectal carci-
noma. In our sample 45% of cases presented with solitary osteomas,
therefore, it is worthwhile considering the diagnosis even in this case
(eg a solitary osteoma can be seen in Figure 1). Previous reports
estimate that 46%-93% of patients with FAP have osteomatous
changes of the jaws,8 and others report that 61%5 of FAP patients
have bony changes associated with the disease of patients with ade-
quate X-ray examination. As the patients in the Finnish registry were
not routinely screened for this condition it is probable that a larger
proportion has the bony changes. It is imperative that specialists
who may be involved in the care may be able to spot extraintestinal
manifestations to expedite the diagnosis, especially when the pres-
ence of osteomas can signify the first presentation of such a dis-
ease.
As osteomas are benign, there are various indications described
in the literature for their removal. Suggested indications are if: they
interfere with normal function or cause deformity8; there is sign of
growth in osteomas situated within the sinuses; their location risks
obstruction of anatomical drainage sites; they cause symptoms of
chronic sinusitis; they risk impinging on important structures such as
the orbit.9 The imaging modality of choice is thin-slice CT to allow a
precise estimation of size and location of the osteoma.8,10 From our
retrospective case series, we are aware of two of the patients having
had surgical treatment for their osteomas. One had a wide frontal
bone excision with bony reconstruction using the iliac crest, and the
other had the osteoma excised.
Although this is a rare diagnosis, FAP has serious clinical signifi-
cance especially if missed, as without prophylactic colectomy/procto-
colectomy the risk of colorectal cancer is almost inevitable. It is
important to ask about osteomas or lumps elsewhere, family history
of gastrointestinal pathology, cancers and gastrointestinal symptoms,
and to refer to a unit with expertise in the field of this hereditary
polyposis if there is any suggestion that this could be FAP. Important
symptoms to ask about are weight loss, diarrhoea, mucous discharge,
rectal bleeding, abdominal pain or cramping, and anaemia status
should also be assessed.8 It is advised that patients with FAP
undergo bowel, upper gastrointestinal, thyroid and possibly hepatic
surveillance given the associated malignancy risk.2,4,8
5 | LIMITATIONS
1. Lack of screening for osteomas, thus it is difficult to know the
accurate incidence and locations in this population.
2. Historical nature of the notes. Usually, osteomas were incidental,
and little information was written about them.
3. Small sample size.
6 | CONCLUSION
We want to raise awareness of the presence osteomas and their role
in FAP, which is a significant life-limiting disease, so that the patient
and family can be screened for this and managed accordingly.
CONFLICTS OF INTEREST
There are no conflict of interests.
ORCID
A. Dickinson http://orcid.org/0000-0003-4559-7819
A. M€akitie http://orcid.org/0000-0002-0451-2404
A. Dickinson1
L. Koskenvuo2
K. Tuomainen1
A. M€akitie1,3
A. Lepist€o2
S. Renkonen1,4
1Departments of Otorhinolaryngology, Head and Neck Surgery,
University of Helsinki, Helsinki University Hospital, Helsinki, Finland
2Department of Gastrointestinal Surgery, University of Helsinki, Helsinki
University Hospital, Helsinki, Finland
3Division of Ear Nose and Throat Diseases, Department of Clinical
Sciences, Intervention and Technology, Karolinska Institute and
F IGURE 1 Orthopantomogram showing a solitary osteoma of the
left mandibular ramus
930 | CORRESPONDENCE: OUR EXPERIENCE
Karolinska Hospital, Stockholm, Sweden
4Department of Biosciences and Nutrition, Karolinska Institutet,
Stockholm, Sweden
Correspondence
Amy Dickinson, Departments of Otorhinolaryngology, Head and Neck
Surgery, University of Helsinki, Helsinki University Hospital, Helsinki,
Finland.
Email: amyjmdickinson@gmail.com
REFERENCES
1. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol
Genet. 2001;10:721-733.
2. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J
Gastroenterol. 2006;101:385-398.
3. Bussey HJR. Familial polyposis coli family studies, histopathology, dif-
ferential diagnosis, and results of treatment. Baltimore: Johns Hopkins
University Press; 1975.
4. Groen EJ, Roos A, Muntinghe FL, et al. Extra-intestinal manifesta-
tions of familial adenomatous polyposis. Ann Surg Oncol.
2008;15:2439-2450.
5. Jarvinen HJ, Peltokallio P, Landtman M, Wolf J. Gardner’s stigmas in
patients with familial adenomatosis coli. Br J Surg. 1982;69:718-721.
6. Bisgaard ML, Fenger K, Bulow S, Niebuhr E, Mohr J. Familial adeno-
matous polyposis (FAP): frequency, penetrance, and mutation rate.
Hum Mutat. 1994;3:121-125.
7. Gardner EJ, Richards RC. Multiple cutaneous and subcutaneous
lesions occurring simultaneously with hereditary polyposis and osteo-
matosis. Am J Hum Genet. 1953;5:139-147.
8. Boffano P, Bosco GF, Gerbino G. The surgical management of oral
and maxillofacial manifestations of Gardner syndrome. J Oral Maxillo-
fac Surg. 2010;68:2549-2554.
9. Jones K, Korzcak P. The diagnostic significance and management of
Gardner’s syndrome. Br J Oral Maxillofac Surg. 1990;28:80-84.
10. Lee DH, Jung SH, Yoon TM, Lee JK, Joo YE, Lim SC. Characteristics
of paranasal sinus osteoma and treatment outcomes. Acta Otolaryn-
gol. 2015;135:602-607.
DOI: 10.1111/coa.13063
Accepted: 7 January 2018
Accuracy of FDG PET-CT response assessment following
radiotherapy alone for head and neck squamous cell
carcinoma: Retrospective analysis of 45 patients
1 | INTRODUCTION
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomogra-
phy-computerised tomography (PET-CT) is established as an
accurate tool for response assessment following concurrent
chemoradiotherapy for head and neck squamous cell carcinoma,
with a high negative predictive value (NPV), guiding selective
surgical intervention.1-3 The phase III PET neck surveillance trial
demonstrated that PET-CT-guided imaging surveillance following
concurrent chemoradiotherapy compared with a planned neck dis-
section achieved similar survival with far fewer neck dissections
and was cost-effective.2 However, the addition of concurrent
chemotherapy to radiotherapy is often contraindicated due to
comorbidity and has not been found to be beneficial to patients
with stage I/II disease, age ≥70 years old, WHO performance sta-
tus ≥2.4 There is a paucity of data to determine whether response
assessment PET-CT after radiotherapy alone is sufficiently accurate
to influence management.
In our centre, we have adopted a policy of observation if a com-
plete metabolic response on PET-CT is achieved following
radiotherapy  chemotherapy.3,5 The aim of this report was to anal-
yse the accuracy of FDG PET-CT response assessment following
radiotherapy alone without a planned neck dissection.
2 | METHODS
2.1 | Ethical considerations
The study was registered with the Institutional Quality Improvement
Board.
2.2 | Study design
A total of 45 consecutive patients with head and neck squamous cell
carcinoma who underwent FDG PET-CT for response assessment
following curative-intent radiotherapy (without chemotherapy)
between 2009 and 2014 were retrospectively identified. Inclusion
criteria were (i) squamous cell carcinoma of the oropharynx, larynx,
hypopharynx or unknown primary, (ii) radiotherapy with curative
intent and (iii) FDG PET-CT as a baseline prior to treatment. Patients
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